- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Alira Health
Alira Health is listed as a mid sized business research supplier in the Scientist.com network, with 8 sites in 8 countries.
View Alira Health on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
8
Countries
8
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Mid sized business
Clinical Consulting
- Regulatory Consulting Ensure that each product or device complies with all FDA rules and regulations.
- Study Budgeting Consulting Request for Consulting Services
Clinical Trials
- ePRO - Electronic Patient-reported Outcome Patient reported outcome collected by electronic methods.
- Patient Recruitment Recruit and retain patients for clinical trials.
- Regulatory Affairs Consulting Receive assistance ensuring compliance with regulatory requirements.
- Site Monitoring Maintain oversight over participant's health during a clinical trial.
- Site Selection Select clinical trial sites with clinicians who recruit, enroll, treat and evaluate trial patients.
- Study/Site Feasibility Study Explore and test study practicality.
Drug Development
- Consulting Services Work with consultants who provide expert advice in various areas of research and technology.
HEOR
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
- Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
- Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
Show all 43 services
Market Access
- Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
- Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
- Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
- Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
- Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
- Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
Show all 15 in Market Access
- Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
- Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
- Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
- Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
- Payer Toolkit Communicate product value to payers utilizing digital and mobile technology (For example, Payer-Facing iPad Models).
- Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
- Study Start Up Consulting Request for RWE/HEOR/Market Access Study Start Up Consulting
- Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
- Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Medical Communications
- Gap Analysis Compare the actual performance of an organization or corporation with potential or desired performance, as ways to effectively analyze resource management or allocation.
- Landscape Analysis Find a cohesive and consistent view of your main organization. Develop initiatives in analyzed areas of operations and analyze chosen key aspects of them.
- Market & Competitor Analyses Evaluating the current therapeutic landscape, identifying unmet needs, and assessing the scientific positioning and data of competitor products.
- Patient Narratives Compliant collection and use of individual patient stories to illustrate the impact of a disease or treatment, often for training or empathy-building purposes.
- Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...
Medical/Commercial
- Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
Old Category HEOR, RWE, Market Access
- Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
- RWE/HEOR/Market Access Disease/Clinical Outcomes Study the course of disease and the possible outcome of disease, including expected frequency.
- RWE/HEOR/Market Access Hybrid Study Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
Real World Evidence & Data
- Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
- Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
- Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
- Secondary Real World Evidence Analyze clinical trial data.
Regulatory Affairs
- Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
- Post Authorization Safety Study (PASS) Evaluate the safety, benefit-risk profile, and risk management of a treatment. These studies are specifically asked for by European Medicines Agency (EMA) and they can be mandatory or voluntary.
- Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
- Website
- www.alirahealth.com
Where it operates
Sites by country, with the cities in each.
-
Canada 1 site
-
France 1 site
-
Germany 1 site
-
Italy 1 site
-
Spain 1 site
Showing 5 of 8 countries.
Work with Alira Health on Scientist.com
For prices, more details, or to contact Alira Health, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.